1-3 of 3
Zhou Fang
Close
Sort by
Journal Articles

An Open-Label, Multicenter,Single-Arm, Phase I Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of XNW5004 in Patients with Relapsed or Refractory Hematologic Malignancies

Zheng Weiwei, Zhou Hui, Xi Zhang, Jing Hongmei, Zhou Dongmei, Zhou Fang, Gao Li, Wan Wei, Song Yaobo, Haung Yan, Xu Linfeng, Hu Yonghan, Le Meijie, Qi Junyuan, Lugui Qiu
Journal: Blood
Blood (2022) 140 (Supplement 1): 9353–9355.
https://doi.org/10.1182/blood-2022-157853
Published: 2022
Journal Articles

Efficacy and Safety of Gilteritinib Vs. Sorafenib As Post-Transplant Maintenance in Patients with FLT3-ITD Acute Myeloid Leukemia

Jason Yeh, Rima M. Saliba, Christopher Wang, Zhou Fang, Bradley Figgins, Sairah Ahmed, Musa Yilmaz, Naval Daver, Rohtesh S. Mehta, Gheath Alatrash, David Marin, Uday R Popat, Richard E Champlin, Elizabeth J Shpall, Betul Oran
Journal: Blood
Blood (2022) 140 (Supplement 1): 7686–7688.
https://doi.org/10.1182/blood-2022-165780
Published: 2022
Journal Articles

A Dynamic Personalized Human 3D Organoid for the Study of the Tumor Microenvironment and Metabolism in Acute Myeloid Leukemia Using Patient-Derived Xenografts

Alejandro De Janon, Madison Stout, Diana Fridlyand, Zhou Fang, Ahmet F. Coskun, Douglas K Graham, Athanasios Mantalaris, Deborah DeRyckere, Nicki Panoskaltsis
Journal: Blood
Blood (2022) 140 (Supplement 1): 1203–1204.
https://doi.org/10.1182/blood-2022-170225
Published: 2022